A detailed history of Birchview Capital, LP transactions in Tela Bio, Inc. stock. As of the latest transaction made, Birchview Capital, LP holds 155,000 shares of TELA stock, worth $266,600. This represents 0.17% of its overall portfolio holdings.

Number of Shares
155,000
Previous 125,000 24.0%
Holding current value
$266,600
Previous $377,000 49.87%
% of portfolio
0.17%
Previous 0.32%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$1.22 - $2.91 $36,600 - $87,300
30,000 Added 24.0%
155,000 $189,000
Q4 2024

Jun 30, 2025

SELL
$2.38 - $3.14 $71,400 - $94,200
-30,000 Reduced 19.35%
125,000 $377,000
Q4 2024

Feb 14, 2025

BUY
$2.38 - $3.14 $297,500 - $392,500
125,000 New
125,000 $377,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $33M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.